AST SpaceMobile's stock fell 6% after insider selling and a launch delay. Rakuten’s Hiroshi Mikitani sold about $154.5 million in ASTS shares, with total insider sales reaching $274 million last quarter. The BlueBird 7 satellite launch was postponed to April 19 from Kennedy Space Center. Deutsche Bank lowered its price target from $139 to $117 amid market concerns.
Enveric Biosciences stock surged over 160% after President Trump signed an executive order to fast-track psychedelic drug reviews. The move also included a $50 million fund for ibogaine research, boosting biotech stocks in the psychedelic sector. ENVB’s rally marks a major shift in the psychedelics market driven by regulatory support.
The International Energy Agency (IEA) warns that the US naval blockade of the Strait of Hormuz increases global energy market instability, potentially affecting oil prices and economic stability over the next two years. The strategic move heightens concerns about supply disruptions in a critical oil transit route, with significant implications for markets and energy security.
Stifel Nicolaus raised Rocket Lab's (RKLB) price target to $105, suggesting nearly 21% upside, while Morgan Stanley also upgraded RKLB to Overweight with the same target. Cantor Fitzgerald maintained an $85 target, citing over 84 successful missions. These analyst ratings reflect growing confidence in Rocket Lab’s recent performance and mission success.
Definium Therapeutics (DFTX) stock reached a 52-week high, rising over 13% in premarket trading after President Trump signed an executive order supporting psychedelic medicine research. The order directs the FDA to expedite research and approval processes for psychedelic treatments targeting mental health disorders, including GAD. The company's CEO praised the move, emphasizing its potential impact on their DT120 program.
ZachXBT identified Kraken as a key platform involved in M token manipulation, citing a $6 billion market cap with only $66 million in app volume. Insider wallets control over 90% of the supply. Kraken joined Binance and Bitget in ZachXBT’s investigation, highlighting concerns over market integrity and potential manipulation in the crypto space.
RAVE, the token of RaveDAO, is approaching a potential 50% decline, with its price trending within a descending channel and nearing a support level around $0.30. The move comes amid ongoing concerns over possible price manipulation, raising fears of further volatility and a significant drop in the token’s value. The situation highlights risks in the current market environment for RAVE holders.